Annual Total Long Term Liabilities
$122.51 M
-$48.35 M-28.30%
31 December 2023
Summary:
Atara Biotherapeutics annual total long term liabilities is currently $122.51 million, with the most recent change of -$48.35 million (-28.30%) on 31 December 2023. During the last 3 years, it has risen by +$79.63 million (+185.70%). ATRA annual total long term liabilities is now -28.30% below its all-time high of $170.86 million, reached on 31 December 2022.ATRA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$77.27 M
-$2.62 M-3.28%
30 September 2024
Summary:
Atara Biotherapeutics quarterly total long term liabilities is currently $77.27 million, with the most recent change of -$2.62 million (-3.28%) on 30 September 2024. Over the past year, it has dropped by -$83.27 million (-51.87%). ATRA quarterly long term liabilities is now -54.78% below its all-time high of $170.86 million, reached on 31 December 2022.ATRA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.3% | -51.9% |
| 3 y3 years | +185.7% | +44.1% |
| 5 y5 years | +842.2% | +394.1% |
ATRA Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -28.3% | +185.7% | -54.8% | +44.1% |
| 5 y | 5 years | -28.3% | +842.2% | -54.8% | +408.2% |
| alltime | all time | -28.3% | >+9999.0% | -54.8% | >+9999.0% |
Atara Biotherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $77.27 M(-3.3%) |
| June 2024 | - | $79.89 M(-3.6%) |
| Mar 2024 | - | $82.89 M(-32.3%) |
| Dec 2023 | $122.51 M(-28.3%) | $122.51 M(-23.7%) |
| Sept 2023 | - | $160.54 M(-2.4%) |
| June 2023 | - | $164.43 M(-2.8%) |
| Mar 2023 | - | $169.25 M(-0.9%) |
| Dec 2022 | $170.86 M(+106.5%) | $170.86 M(+56.8%) |
| Sept 2022 | - | $108.96 M(-3.5%) |
| June 2022 | - | $112.95 M(+58.2%) |
| Mar 2022 | - | $71.40 M(-13.7%) |
| Dec 2021 | $82.73 M(+92.9%) | $82.73 M(+54.2%) |
| Sept 2021 | - | $53.63 M(+47.2%) |
| June 2021 | - | $36.42 M(-21.5%) |
| Mar 2021 | - | $46.41 M(+8.2%) |
| Dec 2020 | $42.88 M(+178.1%) | $42.88 M(+175.9%) |
| Sept 2020 | - | $15.54 M(+1.6%) |
| June 2020 | - | $15.30 M(+0.6%) |
| Mar 2020 | - | $15.21 M(-1.4%) |
| Dec 2019 | $15.42 M | $15.42 M(-1.4%) |
| Sept 2019 | - | $15.64 M(-2.6%) |
| June 2019 | - | $16.06 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $15.62 M(+20.1%) |
| Dec 2018 | $13.00 M(+6.0%) | $13.00 M(+0.9%) |
| Sept 2018 | - | $12.89 M(-0.7%) |
| June 2018 | - | $12.97 M(+0.8%) |
| Mar 2018 | - | $12.88 M(+4.9%) |
| Dec 2017 | $12.27 M(+2339.2%) | $12.27 M(+69.9%) |
| Sept 2017 | - | $7.22 M(-37.4%) |
| June 2017 | - | $11.53 M(+1343.1%) |
| Mar 2017 | - | $799.00 K(+58.8%) |
| Dec 2016 | $503.00 K(+203.0%) | $503.00 K(-4.6%) |
| Sept 2016 | - | $527.00 K(-6.4%) |
| June 2016 | - | $563.00 K(+98.2%) |
| Mar 2016 | - | $284.00 K(+71.1%) |
| Dec 2015 | $166.00 K(-23.1%) | $166.00 K(-8.3%) |
| Sept 2015 | - | $181.00 K(-10.8%) |
| June 2015 | - | $203.00 K(-2.9%) |
| Mar 2015 | - | $209.00 K(-3.2%) |
| Dec 2014 | $216.00 K(-99.6%) | $216.00 K(-99.7%) |
| Sept 2014 | - | $74.74 M(>+9900.0%) |
| June 2014 | - | $179.00 K(-99.8%) |
| Mar 2014 | - | $74.78 M(+22.0%) |
| Dec 2013 | $61.32 M(+813.2%) | $61.32 M |
| Dec 2012 | $6.71 M | - |
FAQ
- What is Atara Biotherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual total long term liabilities year-on-year change?
- What is Atara Biotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly long term liabilities year-on-year change?
What is Atara Biotherapeutics annual total long term liabilities?
The current annual total long term liabilities of ATRA is $122.51 M
What is the all time high annual total long term liabilities for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual total long term liabilities is $170.86 M
What is Atara Biotherapeutics annual total long term liabilities year-on-year change?
Over the past year, ATRA annual total long term liabilities has changed by -$48.35 M (-28.30%)
What is Atara Biotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ATRA is $77.27 M
What is the all time high quarterly long term liabilities for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly total long term liabilities is $170.86 M
What is Atara Biotherapeutics quarterly long term liabilities year-on-year change?
Over the past year, ATRA quarterly total long term liabilities has changed by -$83.27 M (-51.87%)